When you lift weights, the pulling force on your muscles is what makes them grow bigger—not because of hormones or feeling burned out, but because your muscles sense the tension and respond by building more muscle fibers.
Evidence from Studies
Supporting (2)
Community contributions welcome
Load-induced human skeletal muscle hypertrophy: Mechanisms, myths, and misconceptions
This study says lifting weights creates tension in muscles, and that tension alone is what makes muscles grow — not sweating, hormones, or the 'pump' feeling. It says all the other stuff people talk about doesn’t really matter.
Load-induced human skeletal muscle hypertrophy: Mechanisms, myths, and misconceptions
This study says lifting weights creates tension in muscles, and that tension alone is what makes muscles grow — not sweating, hormones, or the 'pump' feeling. It says all the other stuff people talk about doesn’t really matter.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
In healthy adult humans, compare muscle hypertrophy after resistance training with mechanical tension isolated via load-controlled devices (e.g., isokinetic machines with variable resistance) versus matched training with added hormonal suppression (e.g., GnRH analogs) or metabolic inhibition (e.g., lactate blockers), measuring myofibrillar protein synthesis via stable isotope labeling over 12 weeks.
Population: Healthy adult males and females aged 18–40; Intervention: 12-week resistance training program with mechanical tension maintained via load-controlled devices; Comparator: Identical training program with pharmacological suppression of hormonal (e.g., testosterone and cortisol blockade) and metabolic (e.g., lactate and ROS inhibition) stressors; Outcome: Myofibrillar protein accretion via muscle biopsy and stable isotope tracing; Duration: 12 weeks; Control: Placebo pharmacological intervention; Blinding: Double-blind pharmacological control; Randomization: Stratified by baseline muscle mass.
In human skeletal muscle biopsies taken pre- and post-resistance training, assess activation of mTORC1, FAK, and YAP/TAZ via phospho-protein arrays and nuclear localization, while pharmacologically inhibiting each pathway individually (e.g., rapamycin for mTORC1, FAK inhibitor, verteporfin for YAP/TAZ), to determine if hypertrophy is blocked despite preserved mechanical tension.
Population: Healthy adult volunteers undergoing unilateral resistance training; Intervention: Single-session resistance exercise with local infusion of pathway-specific inhibitors (mTORC1, FAK, YAP/TAZ) into the trained muscle; Comparator: Contralateral muscle with saline infusion; Outcome: Changes in phosphorylation status of signaling proteins and myofibrillar protein synthesis rates via muscle biopsy and isotope tracing; Duration: Single session with 24–48h post-exercise sampling; Control: Saline infusion in contralateral limb; Blinding: Double-blind local infusion; Randomization: Random assignment of inhibitor to limb.
Compare muscle hypertrophy in humans undergoing two matched resistance training protocols: one maximizing mechanical tension (heavy load, slow eccentric) and another maximizing metabolic stress (light load, blood flow restriction), with identical volume and frequency, to determine if tension alone drives hypertrophy without metabolic stress.
Population: Untrained healthy adults aged 20–35; Intervention: Two 8-week resistance training arms: Arm A (heavy load, 80–85% 1RM, 3x/week, slow eccentrics) vs. Arm B (light load, 30% 1RM, 3x/week, blood flow restriction); Comparator: Within-subject crossover design with 4-week washout; Outcome: Muscle cross-sectional area via MRI and myofibrillar protein synthesis via biopsy; Duration: 8 weeks per arm; Control: Baseline measurements; Blinding: Participants blinded to protocol type; Randomization: Randomized crossover order.
In humans with genetic variants or CRISPR-edited muscle cells (ex vivo) lacking key mechanosensors (e.g., integrin β1, FAK, or YAP), measure whether resistance training fails to induce myofibrillar protein accretion despite normal mechanical tension exposure.
Population: Individuals with naturally occurring loss-of-function mutations in FAK or YAP/TAZ pathway genes; Intervention: Standardized resistance training protocol (3x/week, 12 weeks); Comparator: Matched controls without mutations; Outcome: Muscle hypertrophy (MRI), myofibrillar protein synthesis (isotope tracing), and pathway activation (biopsy); Duration: 12 weeks; Control: Pre-training baseline; Blinding: Outcome assessors blinded to genotype; Randomization: Not applicable (observational genetic cohort).
Track resistance-trained individuals over 6 months using wearable sensors to quantify mechanical tension (force x time) during each session, and correlate it with longitudinal changes in muscle mass and protein synthesis rates, while controlling for hormonal and metabolic biomarkers.
Population: 100 resistance-trained adults (18–50 years); Intervention: Self-selected resistance training over 6 months; Intervention details: Wearable force sensors on barbells/dumbbells to record tension-time integral per set; Comparator: Individuals with similar training volume but low vs. high tension profiles; Outcome: Muscle mass (DXA), myofibrillar protein synthesis (biopsy + isotope), and serum markers of hormones/metabolism; Duration: 6 months; Control: Baseline measurements; Blinding: Outcome assessors blinded to tension data; Randomization: Not applicable (observational).